Licochalcone A, a natural inhibitor of c-Jun N-terminal kinase 1

Cancer Prevention Research

Volumn 7, Issue 1, 2014, Pages 139-149

  Yao, Ke ^a,b   Chen, Hanyong ^a   Lee, Mee Hyu ^a   Li, Haitao ^a   Ma, Weiya ^a   Peng, Cong ^a   Song, Nu Ry ^a,c   Lee, Ki Won ^c   Bode, Ann M ^a   Dang, Ziming ^b   Dong, Zigang ^a  

^a University of Minnesota Hormel Institute   (United States)

^b ZHENGZHOU UNIVERSITY   (China)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; LICOCHALCONE A; PHOSPHORUS 32; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER CELL CULTURE; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE; CELL STRAIN HCT116; COLON CANCER; CONTROLLED STUDY; EMBRYO; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; ISOTOPE LABELING; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CANCER; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATE; ANIMALS; CELL ADHESION; CELL LINE; CELL LINE, TUMOR; CHALCONES; COLONIC NEOPLASMS; COMPUTER SIMULATION; ENZYME INHIBITORS; FIBROBLASTS; GLYCYRRHIZA; HEK293 CELLS; HUMANS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PLANT EXTRACTS; PROTEIN BINDING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84892410391     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0117     Document Type: Article

References (34)

1. Choi BY, Choi HS, Ko K, Cho YY, Zhu F, Kang BS, et al. The tumor suppressor p16(INK4a) prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity. Nat Struct Mol Biol 2005;12: 699-707.
2. Bode AM, Dong Z. The functional contrariety of JNK. Mol Carcinog 2007;46: 591-8.
3. OhSM, Zhu F, Cho YY, LeeKW, Kang BS, Kim HG, et al. T-lymphokineactivated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation. Cancer Res 2007;67: 5186-94.
4. Yao K, Cho YY, Bergen HR III, Madden BJ, Choi BY, Ma WY, et al. Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2- AP-1 induced cell transformation. Cancer Res 2007;67: 8725-35.
5. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103: 239-52.
6. Xiao L, Lang W. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells. Cancer Res 2000;60: 400-8.
7. Sun M, Isaacs GD, Hah N, Heldring N, Fogarty EA, Kraus WL. Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells. Mol Endocrinol 2012;26: 736-47.
8. Mahalingam D, Keane M, Pirianov G, Mehmet H, Samali A, Szegezdi E. Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines. Br J Cancer 2009;100: 1415-24.
9. Nateri AS, Spencer-Dene B, Behrens A. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 2005;437: 281-5.
10. Chang Q, Zhang Y, Beezhold KJ, Bhatia D, Zhao H, Chen J, et al. Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer. J Hepatol 2009;50: 323-33.
11. Hess P, Pihan G, Sawyers CL, Flavell RA, Davis RJ. Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat Genet 2002;32: 201-5.
12. Shibata S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 2000;120: 849-62.
13. Xiao XY, Hao M, Yang XY, Ba Q, Li M, Ni SJ, et al. Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis. Cancer Lett 2011;302: 69-75.
14. Schrödinger. Schrödinger Suite 2011. New York: Schrödinger, LLC; 2011.
15. Chamberlain SD, Redman AM, Wilson JW, Deanda F, Shotwell JB, Gerding R, et al. Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3- d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity. Bioorg Med Chem Lett 2009;19: 360-4.
16. Kuglstatter A, Ghate M, Tsing S, Villasenor AG, Shaw D, Barnett JW, et al. X-ray crystal structure of JNK2 complexed with the p38alpha inhibitor BIRB796: insights into the rational design of DFG-out binding MAP kinase inhibitors. Bioorg Med Chem Lett 2010;20: 5217-20.
17. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res 2000;28: 235-42.
18. Funakoshi-Tago M, Nakamura K, Tsuruya R, Hatanaka M, Mashino T, Sonoda Y, et al. The fixed structure of Licochalcone A by alpha, betaunsaturated ketone is necessary for anti-inflammatory activity through the inhibition of NF-kappaB activation. Int Immunopharmacol 2010; 10: 562-71.
19. Yao K, Cho YY, Bode AM, Vummenthala A, Park JG, Liu K, et al. A selective small-molecule inhibitor of c-Jun N-terminal kinase 1. FEBS Lett 2009;583: 2208-12.
20. Chen T, Kablaoui N, Little J, Timofeevski S, Tschantz WR, Chen P, et al. Identification of small-molecule inhibitors of the JIP-JNK interaction. Biochem J 2009;420: 283-94.
21. Siddiqui MA, Reddy PA. Small molecule JNK (c-Jun N-terminal kinase) inhibitors. J Med Chem 2010;53: 3005-12.
22. Heo YS, Kim SK, Seo CI, Kim YK, Sung BJ, Lee HS, et al. Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J 2004;23: 2185-95.
23. Katiyar S, Casimiro MC, Dettin L, Ju X, Wagner EF, Tanaka H, et al. Cjun inhibits mammary apoptosis in vivo. Mol Biol Cell 2010;21: 4264-74.
24. Vanden Bush TJ, Bishop GA. CDK-mediated regulation of cell functions via c-Jun phosphorylation and AP-1 activation. PLoS One 2011; 6:e19468.
25. Das M, Jiang F, Sluss HK, Zhang C, Shokat KM, Flavell RA, et al. Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc Natl Acad Sci U S A 2007;104: 15759-64.
26. Messier C, Grenier D. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. Mycoses 2011;54:e801-6.
27. Kwon HS, Park JH, Kim DH, Kim YH, Shin HK, Kim JK. Licochalcone A isolated from licorice suppresses lipopolysaccharide-stimulated inflammatory reactions in RAW264.7 cells and endotoxin shock in mice. J Mol Med (Berl) 2008;86: 1287-95.
28. Chen H, Yao K, Nadas J, Bode AM, Malakhova M, Oi N, et al. Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods. PLoS One 2012;7:e38261.
29. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 1999; 22: 667-76.
30. Bertrand FE, Angus CW, Partis WJ, Sigounas G. Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle 2012;11: 4344-51.
31. Kamp DW, Shacter E, Weitzman SA. Chronic inflammation and cancer: the role of the mitochondria. Oncology (Williston Park) 2011;25: 400-10, 13.
32. Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res 2009; 29: 2727-37.
33. Skrypek N, Duchene B, Hebbar M, Leteurtre E, van Seuningen I, Jonckheere N. The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family. Oncogene 2013;32: 1714-23.
34. Verma G, Bhatia H, Datta M. Gene expression profiling and pathway analysis identify the integrin signaling pathway to be altered by IL- 1beta in human pancreatic cancer cells: role of JNK. Cancer Lett 2012; 320: 86-95.